PROS1 and COVID-19: The present study adds a new dimension to the existing knowledge on the efficacy of anti-S protein human mAbs against COVID-19 based on the hypothesis that mAbs could directly bind to the mutant spike proteins of the Alpha and Delta strains of SARS-CoV-2 to neutralize them.